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The synthesis and characterization of two new tetronic acid zinc (II) complexes of the empirical formulae [Zn(L–H)2(H2O)2]
(1) and [Zn(L–H)2(H2O)(MeOH)]H2O( 2) found within the same crystal are reported. The zinc ions bind through alkoxide and
carbonyl groups of the ligand 3-methoxycarbonyl-5-phenyl tetronic acid (LH) as indicated by 1H NMR and X-raycrystallographic
studies. These complexes promote intra- and intermolecular interactions, such as hydrogen bonding and π stacking, giving place
to the formation of molecular aggregates.
1.Introduction
Tetronic acid derivatives, tetrahydrofurane-2,4-diones
(Scheme 1), represent an important class of oxygen
5-membered heterocyclic compounds containing the β-
diketonate moiety [1]. A classical example of this type of
structure is the molecule of ascorbic acid (vitamin C). These
compounds are structural motifs in many natural products
[2] exhibiting a wide range of biological activities including
antibiotic, antiviral, antineoplastic, and anticoagulant
activity [3]. Recently, 3-carboxamide tetronic acids were
investigated as inhibitors of undecaprenyl pyrophosphate
synthase (UPPS) for use as antimicrobial agents [4] while
compounds which have been isolated from natural products
and exhibit such activity are tetronasin [5], RK-682 (3-
alkanoyl-5-hydroxymethyl tetronic acid) [6, 7], and the
well-known family of compounds named vulpinic acids
[8, 9]. In addition, several nonnatural 3-functionalized
tetronic acids have been reported as antioxidant and
anti-inﬂammatory compounds [6].
Theinterestingbiologicalandstructuraldiversityofthese
compounds has raised the attention of chemists and biolo-
gists by reason of their challenging structural complexity and
their high aﬃnity to various sorts of “biological eﬀectors”
ranging from simple “metal cations” to complex enzymes
[10].
Tetronates,containingtheβ-diketoacidpharmacophoric
motif, could be involved as model ligands for binding with
divalentmetalions,whicharecriticalcofactorsattheenzyme
catalytic site [11].
The coordination chemistry of zinc (II) β-diketonates
has been extensively explored as a model compound for the
understandingofthechemistryofzinc(II)complexes,where
a metal-oxygen bond is formed. The most important and
best role of zinc is as a structural cofactor in metalloproteins.
Even more, the metal β-diketonates including zinc (II)
complexes are a promising class of compounds as inhibitors
of HIV-1 and of integrase (IN), since the active site of
the enzyme interacts with the metal diketonates [12]. It is
well known that zinc (II) activates essential enzymes such
as carboxypeptidase or alcohol dehydrogenase providing
a complex with the active site. Also, the zinc ion is an
important structural component in proteins in nucleic
acid binding (“zinc-ﬁngers” transcription factors) [13, 14].
Meanwhile, zinc (II) ions are directly associated with the
regulation of gene expression through metalloregulatory
proteins. In addition, zinc (II) ions are also present in
most DNA and RNA polymerases [15]. Moreover, the2 Bioinorganic Chemistry and Applications
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Scheme 1: 3-Methoxycarbonyl-5-phenyltetronic acid.
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Figure 1: X-ray structure of the two independent complexes in the asymmetric unit of the metal complex, Zn1 and Zn2.
metalloneurochemistry of zinc (II) is of substantial current
interest; zinc and d-block metals are emerging as signiﬁcant
players in neurophysiology, aging, and neuropathology [16].
Zinc is the second most abundant d-block metal ion in
the human brain, and its distribution varies with relatively
high concentrations found in the hippocampus [17]. It
is interesting to point out that the tetracoordinated zinc
(II) complexes are a promising class of versatile synthons
to supramolecular architectures, since the driving force to
aggregation occurs through the metal center [18], hydrogen
bonds, and π-stacking [19, 20]. Recent development on the
design and synthesis of zinc (II) ﬂuorescent probes including
chemosensors with ﬂuorogenic agents and biosensors has
been done and referred [15].
In the course of our research program on transition
metal complexes with heterocyclic scaﬀolds containing the
β-diketo functionality [21–23], we reported in a recent work
the coordination model of tetronic acids with Cu (II) and Co
(II) ions [10, 24].
In the present paper, we report a detailed investigation of
new zinc (II) complexes, [Zn(L–H)2(H2O)2]( 1) and [Zn(L–
H)2(H2O)(MeOH)]H2O(2),involvingtheβ-diketo-tetronic
acids as “model ligands”. The structure and “supramolec-
ular” arrangements of the isolated complexes have been
investigated by single crystal X-ray crystallography.
The “ligand molecules” have a proton adjacent to the
carbonyl group and consequently can exhibit enol-enol
tautomerism as shown in Scheme 1.
2. Experimental
2.1. Materials and Instruments. A l lr e a g e n t sw e r ep u r c h a s e d
from Aldrich, Fluka, and Acros and were used without
further puriﬁcation. Dry THF was distilled from Na/Ph2CO.Bioinorganic Chemistry and Applications 3
Table 1: Crystal data, structure reﬁnement for [Zn(L–
H)2(H2O)2][Zn(L–H)2(H2O)(MeOH)]H2O.
Empirical formula C24.25H23O12.25Zn
Formula weight 575.80
Temperature 150(2)K
Wavelength 0.68840 ˚ A
Crystal system Monoclinic
Space group C2
Unit cell dimensions
a = 15.274(7) ˚ A, α = 90◦
b = 8.812(4) ˚ A, β =
97.664(4)◦
c = 39.525(18) ˚ A, γ =
90◦.
Volume 5272(4) ˚ A3
Z 8
Density (calculated) 1.451Mg/m3
Absorption coeﬃcient 0.994mm−1
F(000) 2372
Crystal size 0.16 × 0.10 × 0.02mm3
Crystal description colourless plate
Theta range for data collection 2.59 to 25.00◦.
Index ranges −18≤ h≤ 18, −10≤ k≤
10, −48≤ l≤ 48
Reﬂections collected 14618
Independent reﬂections 8420 [R(int) = 0.0388]
Completeness to theta = 25.00◦ 83.4 %
Absorption correction Semi-empirical from
equivalents
Max. and min. transmission 0.9804 and 0.8571
Reﬁnement method Full-matrix least-squares
on F2
Data/restraints/parameters 8420/696/704
Goodness-of-ﬁt on F2 1.132
Final R indices [I > 2 sigma (I)] R1 = 0.0895, wR2 =
0.2373
R indices (all data) R1 = 0.0928, wR2 =
0.2396
Absolute structure parameter 0.17(2)
Largest diﬀ. peak and hole 1.905 and −0.959e.˚ A−3
Melting points were determined on a Gallenkamp MFB-
595 melting point apparatus and are uncorrected. IR spectra
were recorded on a Jasco 4200 FTIR spectrometer. NMR
spectra were recorded on a Varian Gemini-2000 300MHz
spectrometer operating at 300MHz (1H) and 75MHz (13C).
Chemical shifts are reported in ppm relative to DMSO-d6
(1H: δ = 2.50, 13C: δ = 77.16). J values are given in Hz.
The X-ray crystals were obtained from a solution of
methanol diﬀused with diethyl ether. Data were collected
at 150(2)K on a beamline 9.8 of the Synchrotron Radi-
ation Source, Daresbury using a very thin plate but the
mosaicity was still high. The structure was solved by direct
methods and reﬁned on F2 using all the reﬂections. All the
nonhydrogen atoms were reﬁned using anisotropic atomic
displacement parameters and hydrogen atoms were inserted
at calculated positions using a riding model.
2.2. Compound Preparation
2.2.1. 3-Methoxycarbonyl-5-Phenyl Tetronic Acid. The ligand
was prepared, puriﬁed and characterized following our
research group’s method [25–27].
White solid (78%), m.p. 188-189
◦C; (Anal. Found: C,
61.60; H, 4.21. Calc. for C12H10O5: C, 61.54; H, 4.27%); IR
(KBr) νmax/cm−1 (C=O) 1759, 1716, (C=C) 1610. 1H-NMR
δH (ppm, DMSO-d6): 3.64 (3H, s, COOCH3), 5.67 (1H, s,
CH ring), 7.28–7.42 (5H, m, aromatic protons), 8.65 (enolic
OH). 13C-NMR δC (ppm, DMSO-d6): 50.7(COOCH3),
78.8 (C-5), 90.6 (C-3), 127.3/128.8/129.1/135.1 (aromatic
carbons), 162.1 (C-6), 69.3 (C-2), 186.9 (C-4).
2.2.2. General Method of Preparation of the Complexes. The
synthesis of the complexes was accomplished by mixing
the ligand (2 eq) with zinc acetate [Zn(OCOCH3)2 ·2H2O,
1 eq.] in methanol and reﬂuxing the solution for about
2 hours. The resulting solution was evaporated up to a
small volume and the precipitate deposited was collected
by ﬁltration, washed with cold methanol, diethyl ether and
dried in vacuo over P2O5. The structural elucidation of
the complex isolated was accomplished by IR and NMR
spectroscopy as well as X-ray Crystallography. X-ray quality
crystals were obtained from a solution of methanol diﬀused
with ether.
White solid (67%); (Anal. Found: C, 50.53; H, 4.05;
Calc. For Zn2C48.5H47O25: C, 50.34; H, 4.06%). IR (KBr)
νmax/cm−1 (OH) 3654w, 3188br, (C=Oa n dC =C) 1732s,
1650s, 1575s, 1480s, 1419m, (Zn-O) 472w, 428w. 1H-
NMR δH (ppm, DMSO-d6): 3.59 (s, 3H, COOCH3), 5.42
(s, 1H), 7.26–7.35 (m, 5H, aromatic protons), 3.16–3.18 (d,
CH3 methanol), 4.08–4.10 (q, OH, methanol).13C-NMR δC
(ppm, DMSO-d6): 48.6 (COOCH3), 80.4 (C-5), 84.3 (C-3),
126.5/128.2/128.3/136.7 (aromatic carbons), 168.5 (C-6),
172.3 (C-2), 195.1 (C-4).
2.3. X-Ray Crystallography. Parameters for data collection
and reﬁnement are summarized in Table 1.
3. Results and Discussion
3.1. Synthetic Comments, NMR and IR Spectra. The tetronic
acid ligand precursor containing the 5-phenyl group
(Scheme 1) was synthesized according to a new methodology
p r e s e n t e db yo u rg r o u p[ 25–27]. The methodology which
was chosen to be followed has the advantages of small
reaction times and isolation of products in good yields and
satisfactorypurity.Moreover,itisstereoselective;therefore,it
could be followed in case of other chiral tetronic acids. This
strategy is very helpful in situations where chiral molecules
are to be used as ligands in coordination chemistry. The
reaction of 3-methoxycarbonyl-5-phenyl tetronic acid with
zinc (II) acetate gave the bis ligand Zn (II) complexes. The
n e wc o m p l e x e sw e r ec h a r a c t e r i z e db yN M Ra n dI RS p e c -
troscopy, elemental analysis, and X-ray crystallography. The4 Bioinorganic Chemistry and Applications
Table 2: Selected bond lengths [˚ A] and angles [◦] for [Zn(L–H)2(H2O)2][Zn(L–H)2(H2O)(MeOH)]H2O.
Bond Bond length Bond Bond length
Zn(1)–O(5A) 2.062(7) Zn(2)–O(5C) 2.069(7)
Zn(1)–O(5B) 2.062(7) Zn(2)–O(3W) 2.079(8)
Zn(1)–O(1W) 2.104(7) Zn(2)–O(1S) 2.089(7)
Zn(1)–O(2W) 2.109(8) Zn(2)–O(5D) 2.103(7)
Zn(1)–O(3B) 2.115(7) Zn(2)–O(3D) 2.116(8)
Zn(1)–O(3A) 2.154(7) Zn(2)–O(3C) 2.139(7)
O(1A)–C(1A) 1.394(12) O(1C)–C(1C) 1.414(14)
O(1A)–C(6A) 1.457(11) O(1C)–C(6C) 1.443(12)
C(1A)–O(2A) 1.191(12) C(1C)–O(2C) 1.177(13)
C(1A)–C(2A) 1.444(13) C(1C)–C(2C) 1.437(13)
C(2A)–C(5A) 1.391(12) C(2C)–C(5C) 1.390(14)
C(2A)–C(3A) 1.449(12) C(2C)–C(3C) 1.426(15)
C(3A)–O(3A) 1.215(12) O(3C)–C(3C) 1.236(13)
C(3A)–O(4A) 1.337(11) C(3C)–O(4C) 1.339(13)
O(4A)–C(4A) 1.444(13) O(4C)–C(4C) 1.535(16)
C(5A)–O(5A) 1.258(11) C(5C)–O(5C) 1.259(12)
C(5A)–C(6A) 1.530(12) C(5C)–C(6C) 1.551(16)
C(6A)–C(7A) 1.509(14) C(6C)–C(7C) 1.494(17)
C(7A)–C(8A) 1.371(15) C(7C)–C(8C) 1.386(18)
C(7A)–C(12A) 1.393(14) C(7C)–C(12C) 1.385(19)
O(5A)–Zn(1)–O(5B) 90.7 (3) O(5C)–Zn(2)–O(3W) 87.1(3)
O(5A)–Zn(1)–O(1W) 93.9 (3) O(5C)–Zn(2)–O(1S) 94.7(3)
O(5B)–Zn(1)–O(1W) 87.5 (3) O(3W)–Zn(2)–O(1S) 177.9(4)
O(5A)–Zn(1)–O(2W) 88.3 (3) O(5C)–Zn(2)–O(5D) 90.4(3)
O(5B)–Zn(1)–O(2W) 96.4(3) O(3W)–Zn(2)–O(5D) 93.1(3)
O(1W)–Zn(1)–O(2W) 175.4(3) O(1S)–Zn(2)–O(5D) 87.9(3)
O(5A)–Zn(1)–O(3B) 174.5(3) O(5C)–Zn(2)–O(3D) 174.2(3)
O(5B)–Zn(1)–O(3B) 90.3(2) O(3W)–Zn(2)–O(3D) 87.2(3)
O(1W)–Zn(1)–O(3B) 91.5(3) O(1S)–Zn(2)–O(3D) 91.0(3)
O(2W)–Zn(1)–O(3B) 86.2(3) O(5D)–Zn(2)–O(3D) 88.8(3)
O(5A)–Zn(1)–O(3A) 89.6(3) O(5C)–Zn(2)–O(3C) 90.0(3)
O(5B)–Zn(1)–O(3A) 173.1(3) O(3W)–Zn(2)–O(3C) 92.6(3)
O(1W)–Zn(1)–O(3A) 85.5(3) O(1S)–Zn(2)–O(3C) 86.4(3)
O(2W)–Zn(1)–O(3A) 90.5(3) O(5D)–Zn(2)–O(3C) 174.3(3)
O(3B)–Zn(1)–O(3A) 90.0(3) O(3D)–Zn(2)–O(3C) 91.4(3)
Table 3: Hydrogen bonds for [Zn(L–H)2(H2O)2][Zn(L–H)2(H2O)(MeOH)]H2O[˚ Aa n d◦].
D–H···A d(D–H) d(H···A) d(D···A) <(DHA)
O(1S)–H(1S)···O(2D)#1 0.85 1.80 2.651(11) 179.0
O(4W)–H(4WA)···O(2D)#1 0.84 1.83 2.651(11) 162.3
O(4W)–H(4WB)···O(5W) 0.89 2.39 2.77(3) 106.0
O(1W)–H(1WA)···O(2B)#2 0.84(2) 1.84(3) 2.677(10) 170.0(13)
O(2W)–H(2WA)···O(2A)#3 0.84(2) 1.82(2) 2.685(10) 176.0(13)
O(3W)–H(3WA)···O(2C)#4 0.83(2) 1.88(4) 2.698(11) 168.0(12)
1H-NMR spectrum in DMSO-d6 of the complex conﬁrms
the formation of metal-oxygen bonds since the signal of the
acidic proton of the ligand (around 8.65ppm) is absent in
the metal complex.
3.2. Description of the Structures. The molecular structures
of complexes Zn1 and Zn2 are shown in Figures 1 and 2,
whereas selected bond lengths and angles as well the hydro-
gen bond lengths are listed in Tables 2 and 3 consequently.Bioinorganic Chemistry and Applications 5
02A
02AB
02B 02WA
01WB
Zn1A
02BA
01W
02W
Zn1
Zn1A
Zn1B
(a)
05WA
02D
01SA
02CA
03W
01S
02DB
03WB
02C
01SB
05WB
Zn2
Zn2A
Zn2B
(b)
Figure 2: X-ray structure of the metal complexes showing the hydrogen bonds.
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Figure 3: Zn1 chains (red) and Zn2 chains (green).6 Bioinorganic Chemistry and Applications
The structure was solved in space group C2 and reﬁned as
a racemic twin (BASF 0.17) with two similar molecules in
the asymmetric unit. The zinc ions are six-coordinate, each
coordinated to two monodeprotonated, bidentate ligands
which bind through alkoxide and carbonyl groups and are
cis to one another. The coordination sphere about Zn1
is completed by two coordinated water molecules. In the
second molecule (containing Zn2), one of the axial sites is
disordered and has been modeled as 50:50 disorder between
methanol and water (with the oxygen atoms on the same
site), with a further uncoordinated water molecule hydrogen
bonded to the partial occupancy water ligand (Figure 1).
According to the data provided by X-ray Crystallography
Analysis, the complex comprises of three diﬀerent subcom-
plexes: (a) the Zn(L–H)2(H2O)2 which is the molecule 1
centeredonZn1,(b)the[ Zn(L–H)2(H2O)]H2Owhichr epr e-
sents the 50% percentage of molecule 2 centered on Zn2,a n d
(c) the Zn(L–H)2(H2O)(MeOH) which represents the other
50% percentage of molecule 2 centered on Zn2.I fw ea d d
appropriately the above three complexes (100% of complex
(a) + 50% of complex (b) + 50% of complex (c)), then the
molecular formula found is Zn2(L–H)4(H2O)4.5(MeOH)0.5
or Zn2C48.5H47O25.
Hydrogen bonding between the coordinated water
(or methanol) molecules and the uncoordinated carbonyl
groups of neighboring molecules link the complexes into
one-dimensional chains. Each molecule gives rise to an
independent chain, those comprising symmetry equivalents
of Zn2 run parallel to the b axis, while those composed
of symmetry equivalents of Zn1 lie along the ab diagonal
(Figures 2 and 3).
4. Conclusions
The use of 3-methoxycarbonyl-5-phenyl tetronic acid
in reaction with Zn(OCOCH3)2 ·2H2Oh a sy i e l d e d
two mononuclear [Zn(L–H)2(H2O)2]( 1) and [Zn(L–
H)2(H2O)(MeOH)]H2O( 2), complex compounds. The
crystal structure of the complexes shows the existence of two
independent molecules in the asymmetric unit in the crystal
moiety. The complexation is achieved through the oxygens
of the alkoxide groups and the carbonyl functionalities.
Hydrogen bonding between water or methanol molecules
of the unit gives rise to two one-dimensional independent
chains. These models are promising systems for the
development of new supramolecular architectures. Design
and results on the synthesis of zinc (II) ﬂuorescent probes
with chemosensors heterocyclic molecules containing the
β-diketo functionality will be reported in due course.
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